April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Macular Pigment Changes in Pseudophakic Eyes Quantified With Resonance Raman Spectrophotometry
Author Affiliations & Notes
  • A. Obana
    Ophthalmology, Seirei Hamamatsu Gen Hosp, Hamamatsu, Japan
    Photochemical Medicine Department, Photon Medical Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • M. Tanito
    Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan
  • Y. Gohto
    Ophthalmology, Seirei Hamamatsu Gen Hosp, Hamamatsu, Japan
  • A. Ohira
    Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan
  • W. Gellermann
    Physics, University of Utah, Salt lake City, Utah
  • Footnotes
    Commercial Relationships  A. Obana, None; M. Tanito, None; Y. Gohto, None; A. Ohira, None; W. Gellermann, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1717. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Obana, M. Tanito, Y. Gohto, A. Ohira, W. Gellermann; Macular Pigment Changes in Pseudophakic Eyes Quantified With Resonance Raman Spectrophotometry. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1717.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Removal of the crystalline lens by cataract surgery enhances the exposure of the phototoxic short wavelength blue-light to the retina, and could be a risk factor of the development of age-related macular degeneration (AMD). Recently, yellow tinted intraocular lenses (IOL) that absorb blue-light have been recommended for the protection of the retina from phototoxic blue-light. On the other hand, human retina contains macular pigments that absorb blue-light and contribute to the protection from phototoxic damage. Macular pigment optical density (MPOD) changes with aging and AMD, but the change in pseudophakic eyes has not yet been investigated. We quantified MPOD in patients who had implantation of either a clear IOL or yellow IOL.

Methods: : Implantation of clear IOL (SA60AT, Alcon) or yellow IOL (SN60AT, Alcon) were performed in 117 and 125 eyes, respectively. MPOD was measured by resonance Raman spectrophotometry at day 1,4,7,14 and month 1,2,3,4, and 6 after surgery under the approval of our hospital IRB. All subjects signed informed consent forms that complied with the tenets of the Declaration of Helsinki. Eyes with poor (<0.8) post-operative visual acuity and any fundus diseases were excluded. The difference in MPOD between both IOL groups was analyzed by repeated-measurement MANOVA, and factors associated with MPOD were analyzed by multiple regression analysis.

Results: : MPOD in the clear IOL group declined with time (p=0.0003, MANOVA). MPOD was significantly lower in clear IOL group than in yellow IOL group 6 months after surgery (p<0.05). Age and pre-operative myopic refractive error correlated significantly with low MPOD level (p<0.05) in the first month. Diabetes correlated significantly with low MPOD (p<0.05) later than three months after surgery.

Keywords: macular pigment • intraocular lens • oxidation/oxidative or free radical damage 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×